Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - voriconazol - filmovertrukne tabletter - 200 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - voriconazol - filmovertrukne tabletter - 50 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - voriconazol - pulver til infusionsvæske, opløsning - 200 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmascience international ltd - dasatinib - filmovertrukne tabletter - 20 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

yes pharmaceutical development services gmbh - doxorubicinhydrochlorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiske midler - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - miconazol - mundhulegel - 20 mg/g

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

mcneil denmark aps - miconazol - mundhulegel - 20 mg/g

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - miconazol - mundhulegel - 20 mg/g

Den Europæiske Union - dansk - EMA (European Medicines Agency)

merck sharp & dohme b.v. - fosaprepitant - vomiting; cancer - antiemetika og antinauseants, - forebyggelse af kvalme og opkastning i forbindelse med meget og moderat emetogenic kemoterapi mod kræft hos voksne og pædiatriske patienter i alderen fra 6 måneder og ældre. ivemend 150 mg, der gives som en del af en kombinationsbehandling.